Table 2.
Pearson’s correlation analysis and multiple regression analysis of CTRP-1 during pregnancy.
Pregnancy | All (in pregnancy) | GDM (in pregnancy) | NGT (in pregnancy) | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Simple | Multiple regression | Simple | Multiple regression | Simple | Multiple regression | |||||||
RP | P | β | P | RP | P | β | P | RP | P | β | P | |
Week of gestation | 0.000 | 0.996 | − 0.044 | 0.629 | 0.038 | 0.626 | ||||||
Weight | − 0.173 | 0.003 | − 0.065 | 0.393 | − 0.139 | 0.122 | − 0.199 | 0.011 | − 0.038 | 0.773 | ||
Height | 0.084 | 0.154 | 0.135 | 0.135 | 0.026 | 0.743 | ||||||
Waist | 0.056 | 0.572 | − 0.039 | 0.816 | 0.059 | 0.637 | ||||||
Hip | 0.028 | 0.781 | 0.143 | 0.391 | − 0.063 | 0.614 | ||||||
Age | 0.009 | 0.880 | 0.078 | 0.390 | − 0.031 | 0.696 | ||||||
RR systolic | 0.015 | 0.807 | − 0.002 | 0.985 | 0.053 | 0.504 | ||||||
RR diastolic | − 0.057 | 0.332 | − 0.077 | 0.394 | − 0.011 | 0.887 | ||||||
Matsuda Index | 0.269 | < 0.001 | − 0.048 | 0.672 | 0.353 | 0.001 | 0.136 | 0.415 | 0.210 | 0.011 | 0.125 | 0.580 |
Stumvoll first phase index | − 0.257 | < 0.001 | − 0.145 | 0.156 | − 0.241 | 0.028 | − 0.105 | 0.442 | − 0.335 | < 0.001 | − 0.281 | 0.212 |
ISSI-2 | 0.218 | 0.001 | 0.258 | 0.003 | 0.256 | 0.021 | 0.146 | 0.291 | 0.159 | 0.056 | − 0.041 | 0.813 |
AUC insulin | − 0.213 | 0.001 | − 0.106 | 0.322 | − 0.226 | 0.040 | 0.075 | 0.691 | − 0.181 | 0.029 | 0.118 | 0.602 |
AUC glucose | 0.009 | 0.894 | 0.093 | 0.406 | 0.117 | 0.160 | ||||||
HbA1c | 0.160 | 0.006 | 0.156 | 0.027 | 0.259 | 0.004 | 0.238 | 0.018 | 0.119 | 0.130 | ||
Adiponectin | 0.098 | 0.182 | 0.092 | 0.384 | 0.070 | 0.496 | ||||||
usCRP | − 0.079 | 0.184 | 0.019 | 0.836 | − 0.168 | 0.032 | − 0.034 | 0.802 | ||||
Estradiol | − 0.048 | 0.419 | − 0.080 | 0.377 | − 0.027 | 0.736 | ||||||
Bioavailable estradiol | − 0.122 | 0.039 | − 0.045 | 0.515 | − 0.240 | 0.007 | − 0.280 | 0.008 | − 0.015 | 0.849 | ||
Testosterone | − 0.083 | 0.316 | 0.131 | 0.315 | − 0.279 | 0.009 | − 0.255 | 0.042 | ||||
Bioavailable testosterone | − 0.058 | 0.488 | 0.153 | 0.243 | − 0.210 | 0.057 | − 0.533 | 0.063 |
All variables with p < 0.1 were included in the multiple regression analysis to test the joint effect of these parameters on CTRP-1. Variables with a VIF > 3.5 in the multicollinearity diagnostic were excluded from the analysis.
Bold indicates the significance level is p < 0.05.